期刊
DEVELOPMENTAL BIOLOGY
卷 411, 期 2, 页码 277-286出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ydbio.2016.02.002
关键词
GFI1B; SPI1; PU.1; Transcriptional networks; Acute myeloid leukemia; Myelodysplastic syndrome
资金
- Spanish Ministry of Science [SAF2005-04709]
- Madrid Regional Government/UCM [CCG08-UCM/BIO-3997]
- LLR
- MRC Molecular Hematology Unit Intramural Programme
- UCL CBRC
- BLUEPRINT (UK)
- Ramon y Cajal grant [2570594457 Y200200074]
- Jose Castillejo program (JC) [2008-00022]
- SEHH
- ICRETT [ICR/09/102]
- Swedish Foundation for Strategic Research [A3 06:215]
- MRC [MR/N000838/1, MR/M009033/1, MC_U137973817] Funding Source: UKRI
- Cancer Research UK [12796] Funding Source: researchfish
- Medical Research Council [MC_U137973817, G1000801g, MR/N000838/1, MR/M009033/1] Funding Source: researchfish
We identify a mutation (D262N) in the erythroid-affiliated transcriptional repressor GFI1B, in an acute myeloid leukemia (AML) patient with antecedent myelodysplastic syndrome (MDS). The GFI1B-D262N mutant functionally antagonizes the transcriptional activity of wild-type GFI1B. GFI1B-D262N promoted myelomonocytic versus erythroid output from primary human hematopoietic precursors and enhanced cell survival of both normal and MDS derived precursors. Re-analysis of AML transcriptome data identifies a distinct group of patients in whom expression of wild-type GFI1B and SPIT (PU.1) have an inverse pattern. In delineating this GFI1B-SPI1 relationship we show that (i) SPI1 is a direct target of GFI1B, (ii) expression of GFI1B-D262N produces elevated expression of SPI1, and (iii) SPIT-knockdown restores balanced lineage output from GFI1B-D262N-expressing precursors. These results table the SPI1-GFI1B transcriptional network as an important regulatory axis in AML as well as in the development of erythroid versus myelomonocytic cell fate. (C) 2016 Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据